Both Wolfspeed and Intellia Therapeutics are facing market scrutiny from short sellers.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Both Wolfspeed and Intellia Therapeutics are facing market scrutiny from short sellers.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Wolfspeed
manufacturer of wide bandgap semiconductors, focused on silicon carbide and gallium nitride materials
Nothing else this week.
-
Intellia Therapeutics
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
Nothing else this week.